Virgilus Ozoude, DO - Medicare Family Medicine in South Boston, VA

Virgilus Ozoude, DO is a medicare enrolled "Family Medicine" physician in South Boston, Virginia. His current practice location is 101 Aubreys Loop, South Boston, Virginia. You can reach out to his office (for appointments etc.) via phone at (434) 517-3879.

Virgilus Ozoude is licensed to practice in Virginia (license number 0102204899) and he also participates in the medicare program. He does not accept medicare assignments directly but he may accept medicare through third-party (refer to Reassignment section below) and may also prescribe medicare part D drugs. His NPI Number is 1932527355.

Contact Information

Virgilus Ozoude, DO
101 Aubreys Loop,
South Boston, VA 24592-5054
(434) 517-3879
(434) 517-3989



Physician's Profile

Full NameVirgilus Ozoude
GenderMale
SpecialityFamily Medicine
Location101 Aubreys Loop, South Boston, Virginia
Accepts Medicare AssignmentsMedicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs.
  NPI Data:
  • NPI Number: 1932527355
  • Provider Enumeration Date: 04/02/2014
  • Last Update Date: 11/20/2020
  Medicare PECOS Information:
  • PECOS PAC ID: 9638443534
  • Enrollment ID: I20170915001043

Medical Identifiers

Medical identifiers for Virgilus Ozoude such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1932527355NPI-NPPES

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
207Q00000XFamily Medicine 0102204899 (Virginia)Primary

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Virgilus Ozoude allows following entities to bill medicare on his behalf.
Entity NameHalifax Regional Hospital Inc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1588668842
PECOS PAC ID: 4587572805
Enrollment ID: O20040607000050

News Archive

Cancer Research UK's phase I trial results of CHT25 published in Clinical Cancer Research

TWO THIRDS of Hodgkin's lymphoma patients treated with an experimental radioactive cancer therapy responded well to the treatment, reveal the results of a Cancer Research UK phase I trial published in Clinical Cancer Research, today (Tuesday).

Heart attack risk continues to increase among pregnant women, study finds

The risk of having a heart attack while pregnant, giving birth, or during the two months after delivery, continues to increase for American women, a new study finds.

Christian Science Monitor examines effect of economy on U.S. foreign aid targets

The Christian Science Monitor on Monday examined how the Obama administration is "hinting that the economic downturn means the president is unlikely to reach his goal of doubling foreign aid by the end of his four-year term.

McGill University granted 'Orphan Drug Designation' for pulmonary infection drug fenretinide

In addition to their suffering, rare disease patients often have to face the harsh reality that few pharmaceutical companies will ever be able to offer new treatments for their condition because the costs of new treatments will never be recovered from such a small market. But there are ways they can be helped. The U.S. Food and Drug Administration's "Orphan Drug Designation" offers a wide range of benefits that help organizations developing treatments for diseases and conditions affecting fewer than 200,000 patients in the United States.

Arena files lorcaserin hydrochloride MAA with Swissmedic

Arena Pharmaceuticals, Inc. announced today the filing with the Swiss health authority, Swissmedic, of a Marketing Authorization Application (MAA) for lorcaserin hydrochloride, an investigational drug candidate in Switzerland.

Read more Medical News

› Verified 7 days ago

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Virgilus Ozoude is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Virgilus Ozoude, DO
101 Aubreys Loop,
South Boston, VA 24592-5054

Ph: (434) 517-3879
Virgilus Ozoude, DO
101 Aubreys Loop,
South Boston, VA 24592-5054

Ph: (434) 517-3879

News Archive

Cancer Research UK's phase I trial results of CHT25 published in Clinical Cancer Research

TWO THIRDS of Hodgkin's lymphoma patients treated with an experimental radioactive cancer therapy responded well to the treatment, reveal the results of a Cancer Research UK phase I trial published in Clinical Cancer Research, today (Tuesday).

Heart attack risk continues to increase among pregnant women, study finds

The risk of having a heart attack while pregnant, giving birth, or during the two months after delivery, continues to increase for American women, a new study finds.

Christian Science Monitor examines effect of economy on U.S. foreign aid targets

The Christian Science Monitor on Monday examined how the Obama administration is "hinting that the economic downturn means the president is unlikely to reach his goal of doubling foreign aid by the end of his four-year term.

McGill University granted 'Orphan Drug Designation' for pulmonary infection drug fenretinide

In addition to their suffering, rare disease patients often have to face the harsh reality that few pharmaceutical companies will ever be able to offer new treatments for their condition because the costs of new treatments will never be recovered from such a small market. But there are ways they can be helped. The U.S. Food and Drug Administration's "Orphan Drug Designation" offers a wide range of benefits that help organizations developing treatments for diseases and conditions affecting fewer than 200,000 patients in the United States.

Arena files lorcaserin hydrochloride MAA with Swissmedic

Arena Pharmaceuticals, Inc. announced today the filing with the Swiss health authority, Swissmedic, of a Marketing Authorization Application (MAA) for lorcaserin hydrochloride, an investigational drug candidate in Switzerland.

Read more News

› Verified 7 days ago


Family Medicine Doctors in South Boston, VA

Gahear F Hamlor, MD
Family Medicine
Medicare: Medicare Enrolled
Practice Location: 101 Aubreys Loop, South Boston, VA 24592
Phone: 434-517-3879    Fax: 434-517-3989
Fallon Andrea Mattis, M.D.
Family Medicine
Medicare: May Accept Medicare Assignments
Practice Location: 101 Aubreys Loop, Sentara Halifax Family Medicine, South Boston, VA 24592
Phone: 646-835-9001    Fax: 646-835-9001
Nakisha Easley, FNP
Family Medicine
Medicare: Medicare Enrolled
Practice Location: 1129 N Main St Ste H, South Boston, VA 24592
Phone: 434-517-6180    Fax: 434-517-6179

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.